Evidence map›Paper›PMID 22483012›Full record

ArticleBiomaterials2012

Chitosan-based scaffolds for the support of smooth muscle constructs in intestinal tissue engineering.

Elie Zakhem, Shreya Raghavan, Robert R Gilmont, Khalil N Bitar

Abstract read
In one paragraph

Article in Biomaterials, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Addressing Key Questions in Organoid Models: Who, Where, How, and Why?International journal of molecular sciences · 2023
    Review
  5. Review
  6. Regenerative medicine technologies applied to transplant medicine. An update.Frontiers in bioengineering and biotechnology · 2022
    Review
  7. Review
  8. Review
  9. Article
  10. Building Scaffolds for Tubular Tissue Engineering.Frontiers in bioengineering and biotechnology · 2020
    Review
  11. Review
  12. Review
  13. Article
  14. Bioengineering the gut: future prospects of regenerative medicine.Nature reviews. Gastroenterology & hepatology · 2016
    Review
  15. Biomaterials for hollow organ tissue engineering.Fibrogenesis & tissue repair · 2016
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Elie ZakhemWake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, NC 27101, USA.
Shreya Raghavan
Robert R Gilmont
Khalil N Bitar

Funding

Myogenic Control Mechanisms of Circular Muscle of the Rectosigmoid ColonR01DK042876 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI BITAR, KHALIL N · 1991 to 2011
$3.2M
Restoration of Fecal Continence in Aging IASR01DK071614 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI BITAR, KHALIL N · 2008 to 2012
$1.6M
NIDDK NIH HHS R01 DK-042876NIDDK NIH HHS R01 DK042876NIDDK NIH HHS R01 DK-071614NIDDK NIH HHS R01 DK071614
6 · The paper itself

Abstract

Intestinal tissue engineering is an emerging field due to a growing demand for intestinal lengthening and replacement procedures secondary to massive resections of the bowel. Here, we demonstrate the potential use of a chitosan/collagen scaffold as a 3D matrix to support the bioengineered circular muscle constructs maintain their physiological functionality. We investigated the biocompatibility of chitosan by growing rabbit colonic circular smooth muscle cells (RCSMCs) on chitosan-coated plates. The cells maintained their spindle-like morphology and preserved their smooth muscle phenotypic markers. We manufactured tubular scaffolds with central openings composed of chitosan and collagen in a 1:1 ratio. Concentrically aligned 3D circular muscle constructs were bioengineered using fibrin-based hydrogel seeded with RCSMCs. The constructs were placed around the scaffold for 2 weeks, after which they were taken off and tested for their physiological functionality. The muscle constructs contracted in response to acetylcholine (Ach) and potassium chloride (KCl) and they relaxed in response to vasoactive intestinal peptide (VIP). These results demonstrate that chitosan is a biomaterial possibly suitable for intestinal tissue engineering applications.

Indexed as

AnimalsCells, CulturedChitosanIntestinesMicroscopy, Electron, ScanningMuscle, SmoothPorosityRabbitsTissue EngineeringTissue ScaffoldsChitosan

Identifiers

PMID22483012
PMCPMC3334429

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.